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PREPARATIVE  PURIFICATION  OF  THE  RAT MAST CELL 
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A  chymotrypsinlike enzyme  was  localized  to  rat  mast  cell  granules  by 
histochemical techniques 25 yr ago (1) and was subsequently further demon- 
strated by the cleavage of synthetic substrates with whole cells (2), cell extracts 
(3), and granule preparations (4-6).  The enzyme, termed "chymase" (3), was 
purified to a specific activity of approximately 60 U/rag from rat thyroid (7) and 
peritoneal mast cells (8) and was shown to have an apparent molecular weight 
of 23,000  (8)  to  29,000  (5)  and to  be  cationic based  upon its  electrophoretic 
mobility at alkaline pH (4, 6). The synthetic substrate specificity was similar 
to  that  of pancreatic  a-chymotrypsin  and  the  active  site  reactivity  with 
irreversible inhibitors indicated the presence of serine and histidine residues (8). 
The development of a  preparative method for the isolation of the rat mast 
cell chymase has now permitted its purification to homogeneity, as assessed by 
analytical techniques, and the demonstration of a  single cationic polypeptide 
chain composition. The activity of the chymase in the mast cell granule is 
partially masked by its binding to the macromolecular proteoglycan heparin 
(9,  10), with which it is released by immunologic activation of the isolated rat 
mast cell (10, 11). Further, the active site of soluble chymase is inhibited by 5- 
hydroxytryptamine (5-HT) 1 but not by histamine. Thus, the expression of the 
proteolytic activity of mast cell granule chymase is regulated by two additional 
mediator components of the mast cell granule. 
Materials and Methods 
a-Chymotrypsin, three times crystallized, N-benzoyl--.-tyrosine  ethyl ester (BTEE), D-trypto- 
phan methyl ester, histamine, free base and dihydrochloride, 5-hydroxytryptamine  hydrochloride, 
and ~l-tosylamide-2-phenyl-ethylchloromethyl  ketone (TPCK) (Sigma Chemical Co., St. Louis, 
Mo.);  casein,  Hammersten quality and N-a-tosyl-L lysine chloromethane ketene  (TLCK) HC1 
(ICN Pharmaceuticals Inc., Cleveland, Ohio); porcine intestinal heparin, 130 U/ml and sucrose- 
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ultra  pure (Schwarz/Mann Div.,  Becton, Dickinson & Co.,  Orangeburg, N.Y.);  deoxyribonuclease 
(Calbiochem,  San Diego,  Calif.);  Aquasol, carrier free [35S]sulfate  as H2SO4  and ~251  (New 
England Nuclear, Boston, Mass.);  Metrizamide, analytical  grade (Accurate Chemical & Scientifc 
Corp., Hicksville,  N.Y.); Sephadex G-75, Sepharose 4B, and activated CH-Sepharose (Pharmacia 
Fine Chemicals, Piscataway, N.J.);  Dowex 1-X2,  chloride  form, 100-200 mesh and polyacrylamide 
(Bio-Rad  Laboratories, Richmond,  Calif.);  2-iodoacetamide  and $-mercaptoethanol  (Eastman 
Kodak Co.,  Rochester, N.Y.); cellulose  nitrate  tubes  number 331101 (Beckman Instruments, Inc., 
Spinco Div., Palo Alto, Calif.);  PM-10 ultrafiltration  membranes  (Amicon Corp., Lexington, 
Mass.);  and Sprague-Dawley rats  (Gofmoor Farms, Southborough, Mass.)  were obtained as  noted. 
Affinity  chromatography gel was prepared by mixing 26.7  mg of  n-tryptophan methyl ester  in 
6 ml of 0.1 M  NaHCO3  with 1 g of  activated CH-Sepharose according to the instructions  of  the 
manufacturer (Pharmacia Fine Chemicals). Analytical acid disc  gel  electrophoresis,  pH 4.3,  and 
alkaline disc  gel electrophoresis  were performed as described (12).  Electrophoresis in 6 cm 10% 
polyacrylamide  gels containing  0.1% sodium  dodecyl  sulfate (SDS)  (13) utilized molecular 
weight standards of  ovalbumin (43,000),  chymotrypsinogen A  (25,700),  a-chymotrypsin (approxi- 
mately 24,000),  and  ribonuclease A (12,500);  the  chymase and each marker protein  were alkylated 
by incubation for 1 h at 37°C in 0.05  M  iodoacetamide  in the presence of  8 M  urea and 1% SDS 
immediately before application to the gels (14).  The chymase and a-chymotrypsin were also 
reduced by 0.01  M  2-mercaptoethanol  in  the  presence of  8 M  urea and 1% SDS and then alkylated 
and run in the same way. The SDS and alkaline and acid disc  gels  were stained with 0.1% 
Coomassie Blue dye for  protein (13). 
Six sucrose density gradients of 12 ml each were formed on a 1-ml cushion of  60% sucrose in 
0.0075  M  Tris,  pH 7.4 in 9/16-inch  diameter cellulose  nitrate  tubes by mixing equal volumes of  5 
and 30% sucrose in the same buffer  in a Buchler gradient maker (Buchler Instruments Div. 
Searle Analytic Inc.,  Fort Lee, N,J.).  The gradients were kept on ice  for  30  min and the samples 
were layered on the gradient surface. The gradients were centrifuged in a Beckman L2-65B 
ultracentrifuge in a SW40 Ti rotor (Beckman Instruments)  at 210,000 g at the bottom of the 
gradient for 5 h or at 3,000  g at the  bottom of  the gradient for 1 h. The samples were collected 
from the bottom with a Beckman fractionator. 
Isolation  of  Rat Mast Cells. The cells  of 100 male and female Sprague-Dawley rats,  each 
weighing 200-300 g, were collected  by lavage of  the peritoneal and thoracic  cavities  of  each rat 
with 20 ml Tyrode's buffer  containing 0.1% gelatin  and 50 ftg/ml  commercial heparin. Mast cells 
were  isolated  as  previously described (11,  15)  by  centrifugation  through 22.5%  wt/vol  Metrizamide. 
The mast cell  purity,  determined by a differential  count of  the nucleated cells  in smears stained 
with toluidine  blue, was 90-95% with a yield  of  approximately 106  mast cells  per rat (11). 
Labeling and Isolation of Rat Mast Cell Heparin.  Mast cells, isolated as described above, 
were radiolabeled in vitro by mixing 4  x  107 mast cells in 1.0 ml of Tyrode's buffer containing 
0.1% gelatin and 10/~g/ml deoxyribonuclease (TGD)  with 10 mCi [~S]sulfate in 1.0 ml of Hanks' 
balanced salt solution and Eagle's basal medium (9).  After incubation for 4 h  at 37°C, the cells 
were washed six times by suspending with TGD  and sedimenting at 400 g  for 5 min at room 
temperature. The cells were frozen and thawed six times, and the solution was brought to 1 M 
with NaC1 and incubated for 30 rain at room temperature. The mixture was centrifuged at 400 g 
for 5  rain to remove cellular debris, and the supernate was applied to a  1  ×  15-cm  column of 
Dowex 1 equilibrated in 1 M NaC1.  The column was eluted with 1, 3, and 4 M NaC1 at 15 ml/h 
(16). Fractions were assayed for heparin content by metachromasia with Azure A (11, 17) and for 
~5S with a Searle Mark III liquid scintillation spectrometer. The 3 M eluate fractions containing 
the heparin (9) were pooled, dialyzed against distilled water, lyophilized, and applied in a  1-ml 
vol of 2 M NaC1  to a  1  ×  50-cm column of Sepharose 4B equilibrated in 2 M NaC1.  The column 
was eluted with 2 M NaC1  at a  flow rate of 4 ml/h, and 1-ml fractions were assessed for ~S and 
heparin by  metachromasia. The  [~S]heparin cochromatographed with the chemically defined 
heparin,  thereby giving a  broad  peak  with a  molecular weight of approximately 750,000,  as 
previously  reported  for  heparin  labeled  for  4  h  in  vitro  (9)  with  the  same  markers.  The 
[35S]heparin  was pooled,  dialyzed against distilled  water, lyophilized,  and stored at -70°C. 
Assay  of  the  Chymase.  The chymase was measured by  its  cleavage of  the  specific  chymotrypsin 
synthetic ester  substrate BTEE  (18)  or of ~zSI-labeled  casein.  The BTEE assay was performed as 
described (19)  by measurement of  the time-related linear increase in absorbance at 256 nm in a 
Beckman  DU  spectrophotometer, and the change in absorbance per minute was converted to R.  YURT  AND  K.  F.  AUSTEN  1407 
micromoles  of  substrate  cleaved  per  minute.  The  assay  detected  2  ~g  of  commercial  a-chymotryp- 
sin which had an activity  of  45 U/mg; a unit  is arbitrarily  defined  as the amount of  enzyme 
required  to  cleave  1.0/zmol  BTEE/min at  25°C. 
500 pg  of  casein  was  labeled  with  99/zCi  1251  by  the  insolubilized  lactoporoxidase  method (20), 
and  the  mixture  was  filtered  on  a  0.7 x 50-cm  column of  Sephadex G-50  equilibrated  in  0.0075  M 
Tris, pH 7.8,  containing  0.15  M  NaCI. 1.5-ml  fractions  were collected,  and the '251-1abeled 
material  that  filtered  in  the  void  volume of  the  column  was  pooled  and  dialyzed  for  I  h against  5 
liters  of  column buffer.  The '251-1abel  in  a  fraction  of  the  dialyzed  material  was  96% precipitated 
by  exposure  for  20  min  at  room  temperature  to  5% trichloroacetic  acid  followed  by  centrifugation 
at  8,000  g, or  4  min in  a  Beckman microcentrifuge  (Beckman  Instruments,  Wilmington,  Mass.). 
The specific  activity  of  the  labeled  casein  was  approximately  40  Ci/mmol.  The  caseinolytic  assay 
was  carried  out  according  to  the method  of  Kunitz  as  described  by Laskowski (21)  for  unlabeled 
substrate.  25 /~I of '~SI-casein,  4,000-5,000  cpm, was added to 1.5-mi  microcentrifuge  tubes 
containing  25 ~zl  of  0.08  M Tris,  pH 7.8  with  0.02  M CaClz.  The mixture  was brought  to  a final 
volume of  100/zl  with  either  0.15  saline  or  enzyme  portions  in  0.15  M saline,  and  the  proteolytic 
reaction  was carried  out for 20 rain  at 37°C.  The reaction  was terminated  by the sequential 
addition  of  0.4  ml  of  0.625%  unlabeled  casein  which had  been  adjusted  to  pH 9.0  with  1  M NaOH 
and 0.6 ml of 5% trichloroacetic  acid.  After  20 min at room temperature,  this  mixture was 
centrifuged  at 8,000  g for 4 min,  and the unprecipitated  1251  was measured by counting  the 
supernate  in a gamma spectrometer.  '251-1abeled  fragments  of  casein  were released  in a linear 
relationship  to  the  dose  of  a-chymotrypsin  in  the  range  between 2  and 10  ng. The chymase was 
quantitated  from  a  standard  curve  generated  with  a-chymotrypsin. 
Protein  was determined  by measurement  of  the  optical  density  at  280  nm and was converted 
to micrograms from a standard  curve  relating  known amounts of  a-chymotrypsin  to its  optical 
density  at 280 nm. One optical  density  unit  equaled  0.490  mg of  a-chymotrypsin  as previously 
reported  (22). 
Results 
Isolation of  the Chymase.  Purified rat mast cells  were suspended in 40 ml 
of  0.0075 M  Tris,  pH 7.4 containing 0.01 M  NaCI, 8 × 10  -4 M  MgCI2 and 10/zg/ 
ml deoxyribonuclease at a concentration of  4.25 ×  10  e  cells/ml.  The cells  were 
frozen and thawed six times, and the cellular debris was sedimented at 400 g 
for 10 rain at room temperature. The supernate was decanted and centrifuged 
at 3,000 g  for 20 rain at 4°C to obtain a granule pellet (6, 11) and granule 
exchange  supernate. The granule exchange  supernate was made  1 M  with 
respect to NaCI,  and the granule pellet  and the cellular debris were each 
brought to a  5-ml vol of 1.0 M  NaCl.  Aider 30 min of incubation at room 
temperature, each of  the subcellular fractions was directly  assayed for  esterase 
activity and for protein content. Chymotryptic activity  was not detected in the 
granule exchange supernate which contained 31.6 mg  protein. The cellular 
debris, which is known  to retain membrane  adherent granules (23),  and the 
granule pellet  fraction contained a combined chymase activity of 63.4 U  and 
42.8 mg of  protein. 
The chymase-containing fractions were pooled and adjusted  to a final  concen- 
tration of  0.01 M  Tris,  pH 9.0 and 0.01% gelatin in 1 M  NaCI. The sample was 
applied to a 1 ×  20-cm column of  Dowex  1 equilibrated in 0.01 M  Tris,  pH 9.0 
containing 0.01% gelatin and 1 M  NaCl and eluted with this buffer; and 10 4- 
ml fractions were collected.  The column was further eluted with 20 ml of  3 M 
NaCl and 20 ml of  4 M  NaCI (Fig.  1). Protein and esterase activity  eluted with 
the starting  buffer,  whereas heparin eluted in the 3 M  NaCI. Minimal amounts 
of  protein and no heparin or chymase were found in the 4 M  NaCI eluate. 
The chymotryptic activity in the Dowex  1 eluate, 4-16 ml, was pooled and 1408  PURIFICATION  OF  THE  RAT  MAST  CELL  CHYMASE 
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FIG.  1.  Dowex  1 chromatography of rat mast cell granule and granule-membrane frac- 
tions treated with 1 M NaC1.  The width of a  bar is equal to a  fraction volume. Fractions 
were assayed for chymase with BTEE  as substrate,  for heparin by metachromasia with 
Azure A, and for protein by absorbance at 280 nm. 
concentrated to 1.1 ml by ultrafiltration on a  PM-10 Amicon membrane, and a 
1-ml sample was applied to a  1 ×  45-cm column of Sephadex G-75 equilibrated 
at 4°C in 0.01 M Tris, pH 7.8 containing 1.2 M KC1 (8) and 0.01% gelatin. The 
sample was filtered in the same buffer, and 0.6-ml fractions were collected at a 
flow rate  of 2  ml/h.  The  chymotryptic activity (Fig.  2)  filtered in the  same 
position as  chymotrypsinogen A  at an  apparent  molecular weight of 25,000, 
while more than 50% of the protein filtered at a higher molecular weight. 
Fractions 27 through 34 were pooled and dialyzed against 5 liters of 0.05  M 
Tris,  pH  8.0  at  4°C  for  1  h.  The  sample  was  applied  over  30  rain  at  room 
temperature to a  300-~1 column of D-tryptophan methyl ester coupled to CH- 
Sepharose equilibrated in 0.05 M Tris, pH 8.0. The column was eluted with the 
equilibrating buffer until the optical density of the eluate fractions was zero, 
and the chymase was then eluted according to the methods for (x-chymotrypsin 
(24) with 0.1  M acetic acid, pH 3.0.  The acetic acid-containing fractions were 
placed on ice, and each was adjusted to pH 7.0 by the addition of 75 ~l of I  M 
Tris. The initial eluate contained a broad peak of protein devoid of esterolytic 
activity (Fig. 3), whereas the acetic acid eluate contained a coincident peak of 
protein and chymotryptic activity. The specific activity of the affinity chroma- 
tography-purified material was 67.8 U/mg of protein and represented a  78-fold 
purification  with  an  overall  yield  of  23%  relative  to  the  activity  in  the 
solubilized cellular debris  and granule pellet.  The single fraction containing 
the chymase was dialyzed against 5 liters of 0.0075 M Tris, pH 7.8 at 4°C for 1 h 
and stored at 4°C  in a  polycarbonate tube.  The specific activity of two other R.  YURT  AND  K.  F.  AUSTEN  1409 
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Fro. 2.  Sephadex G-?5 gel  filtration  ofchymase-containing fractions  obtained from Dowex 
1. The filtration characteristics  of the standards were determined in separate analyses. 
Fractions were assayed for protein ($  @) and chymase activity (©  O). 
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F1o. 3.  D-tryptophan methyl ester-CH  Sepharose  affinity chromatography  of chymase- 
containing fractions from the Sephadex G-75 step. After collection of 10 1-ml fractions, 0.1 
M acetic acid, pH 3.0 was applied and 1-ml fractions were again collected. Fractions were 
assessed for protein (~  O) and chymase activity (O  O). 
purified preparations was  45.1  and 62.4 U/mg protein,  and the percent yields 
were 12 and 25%, respectively. 
Chymase  Purity  and  Function.  The  purity  of the  isolated  enzyme  was 
assessed by electrophoresis of 10-/~g samples in replicate acid disc gels. One gel 
was stained,  and a  replicate gel was sliced and each section eluted for 48 h  at 
4°C in 200/~l of 0.05 M  Tris, pH 8.0 containing 0.5 M  NaC1 and 0.01% gelatin. 
15% of the activity applied was eluted in the area corresponding to the stained 
protein band,  whereas  <1%  was recovered at the cathode in the absence of a 
stained band in the region of the dye front (Fig. 4). Analytic alkaline disc gel 
electrophoresis of 10/~g of purified chymase demonstrated no stainable protein 
bands,  thereby indicating that the charge of the enzyme was such that it did 
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FIG.  4.  Acid  disc  gel  electrophoresis of purified  chymase.  Gels were  run in duplicate, 
with  one  being  stained  and  the  other  sliced  and  eluted  for  assessment  of proteolytic 
activity on ~25I-casein. 
10/~g of purified chymase and 10 ftg of ~-chymotrypsin were each alkylated, 
reduced, or reduced and alkylated and then applied to SDS analytical electro- 
phoresis gels.  The alkylated chymase presented a  single  stained band  (Fig.  5 
A)  with  a  mobility  similar  to  that  of alkylated  a-chymotrypsin  (Fig.  5  B). 
Based on the position of the marker proteins ovalbumin, chymotrypsinogen A, 
and  ribonuclease  A,  the  molecular  weight  of chymase,  like  that  of the  ~- 
chymotrypsin, is apparently 25,000.  Exposure to conditions of reduction (Fig.  5 
C)  or  reduction  and  alkylation  (Fig.  5  E)  did  not  change  the  mobility  of 
chymase; whereas ~-chymotrypsin,  after reduction (Fig.  5 D) or reduction and 
alkylation  (Fig.  5  F),  migrated  as two bands  as previously reported  for this 
enzyme (13). 
The K, and Vmax were determined from the rate of hydrolysis of BTEE at six 
substrate  concentrations  between  5.35  x  10  -5  M  and  1.07  x  10  -3  M  by the 
purified  chymase.  A  double  reciprocal  plot  of 1/v  vs.  1/s  was  linear  with  a 
correlation coefficient oft =  0.999 and gave a Km of 1.56  x  10 -3 M  and a  Vmax of 
67.8  ~mol/min  per mg.  In the same experiment  ~-chymotrypsin  had  a  K.  of 
1.17  x  10  -3 and a  Vma  x of 46.4 /~mol/min per mg. 
Inhibitors  of Purified  Chymase.  5  /~g of the purified chymase and 5  ftg of 
~-chymotrypsin were each incubated in 2  x  10  -4 M TPCK,  1  x  10  -3 M TLCK, 
or solvent for the inhibitors in a  volume of 75/zl at 24°C; the solvent consisted R.  YURT AND  K.  F.  AUSTEN  1411 
Fro.  5.  SDS-polyacrylamide gel electrophoresis of alkylated purified chymase (A), alkyl- 
ated  a-chymotrypsin (B), reduced  purified chymase  (C), reduced  a-chymotrypsin  (D), 
reduced and alkylated purified chymase  (E), and reduced and alkylated a-chymotrypsin 
(F). Electrophoresis is from top to bottom and the position of the tracking dye is indicated 
at the bottom. 
of 0.03 M  Tris, pH 7.8,  0.03 M  CaC12,  and 5% methanol.  The esterase activity 
was  assessed  after 1,  2,  4,  and  8  h  of incubation.  In the  absence  of inhibitor 
there  was  no loss of enzyme activity through the  first 4  h  and  a  30 and  10% 
reduction by 8 h for chymase and a-chymotrypsin, respectively. TLCK produced 
no  change  in  activity  of either  a-chymotrypsin  or  chymase  as  compared  to 
enzyme  incubated  in  solvent  buffer  alone.  In  contrast,  in  the  presence  of 1412  PURIFICATION  OF  THE  RAT  MAST  CELL  CHYMASE 
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Fro. 6.  The inhibition of the proteolytic activity of the purified chymase  by 5-HT. The 
mean value for the duplicate points is plotted and the bars express the range of the 
duplicates. 
TPCK, both enzymes showed a time-dependent loss of activity, with a-chymo- 
trypsin being completely inhibited at 2 h  and chymase at 8 h. 
Because  indoles have  been  shown to  inhibit  a-chymotrypsin (25) and  the 
chymotrypsinlike enzyme of the mouse mastocytoma (26), and 5-HT appears to 
compete with diisopropylfluorophosphate (DFP)  for a  binding site in the rat 
mast cell granule (27), the effect of 5-HT on the purified rat mast cell chymase 
was investigated. 5 ng of purified chymase was preincubated for 1 h  at room 
temperature  with  buffer  or  varying concentrations of 5-HT  HC1  in  a  final 
volume of 75 ~l containing 0.03 M Tris, pH 7.8,  and 0.005 M CaC12. Duplicate 
samples were assessed for proteolytic activity on the  125I-casein substrate.  A 
dose-dependent inhibition of the chymase (Fig.  6)  was observed from 10  -3  to 
10 -2 M 5-HT with a 50% inhibitory dose of 3  x  10 -3 M. 
Because 5-HT and histamine have been shown to compete for binding sites 
on the rat mast cell granule (23) that are presumed to be carboxyl residues on 
the granular protein  (28, 29), the  effect of histamine on the 5-HT-mediated 
inhibition of the chymase was determined. Histamine was prepared by titrating 
0.9 M histamine base in distilled water with 0.9 M histamine hydrochloride in 
distilled water to a pH of 7.8.  5 ng of purified chymase were preincubated for 1 
h  at  room  temperature  with  buffer  alone,  300  mM  histamine,  increasing 
concentrations of 5-HT, and increasing concentrations of 5-HT in the presence 
of histamine in a  final volume of 75  ~l containing 0.03  M  Tris,  pH 7.8,  and 
0.005 M CaC12. Duplicate samples were assessed for proteolytic activity on the 
'25I-casein substrate. The dose-related inhibition of  chymase was again observed 
with 5-HT alone (Fig. 7).  5-HT at 3.75 mM gave 55% inhibition, whereas 300 
mM histamine produced only 20% inhibition. When histamine and 5-HT were 
introduced together, the inhibition of chymase was approximately the same as 
that observed with 5-HT alone. 
Interaction  of Rat Mast  Cell Heparin  with Purified Chymase.  Previous 
experiments  in  which  isolated  rat  mast  cell  granules  were  solubilized  and 
chymase activity and  [35S]heparin  then assessed  suggested a  molar ratio of R.  YURT  AND  K.  F.  AUSTEN 
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FIG.  7.  Inhibition of the proteolytic activity of purified chymase by varying concentrations 
of 5-HT. The mean value for the duplicate points is plotted and the bars express the range 
of the duplicates. 
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chymase to macromolecular heparin in native granules of 40 to 1 (10). Purified 
chymase and purified [~S]heparin of 750,000  mol wt were mixed in various 
ratios,  and  complex  formation  was  assessed  by  ultracentrifugation  of the 
mixture through sucrose density gradients. In each experiment 4,800 cpm (0.78 
/~g) [~S]heparin in a  10-/~l vol was added to varying amounts of the purified 
enzyme to give a final volume of 30 ~l in 0.0075 M Tris, pH 7.4. Each mixture 
was incubated on ice for  1 h  and applied to  a  13-ml sucrose gradient.  In a 
typical experiment 0.33, 0.44, and 1.1/~g of chymase, respectively, were added 
to [~S]heparin to give molar ratios of approximately 12:1, 16:1, and 40:1. These 
mixtures, [~S]heparin alone, 1.1 P4~ chymase alone, and isolated rat mast cell 
granules containing approximately 1.5 ~g chymase, were centrifuged at 210,000 
g  at the bottom of the gradient at 2°C for 5 h. ARer 200-~1 portions had been 
collected until each tube was empty, the bottom portion of each tube was cut 
off and washed with 200  ~1  of 0.05  M  Tris,  pH 7.4 containing 0.5 M  NaC1. 
Alternate samples of the gradient, a portion of the wash fluid from the bottom 
of the  tube,  and  the  bottom portion of the  tube  itself were  suspended in 
scintillation fluid and counted for [~S]heparin. In addition the 200-~1 gradient 
fractions  of the  chymase  alone,  the  isolated  granules,  and  the  1:40 molar 
mixture of heparin and chymase were assayed for chymase content by diluting 
each  sample  to  1:10 with  physiologic saline  containing  0.01%  gelatin  and 
measuring proteolytic activity with '25I-casein.  The chymase alone stayed at 
the top of the gradient  (Fig.  8 A) but only 10%  of the activity applied was 
recovered.  [~S]heparin alone (Fig.  8 B) moved slightly into the gradient and 
70% of the activity applied was recovered. At a  h12 ratio 34% (Fig. 8 C) and at 
a  1:16 ratio  40%  (Fig.  8  D)  of the  [~S]heparin recovered sedimented to the 
bottom of the tube, and the overall recovery in these experiments was approxi- 
mately 70%. In the 1:40 mixture all of the [~S]heparin recovered sedimented to 
the bottom of the tube with a total recovery of 45%, representing a combination 
of the counts in the wash fluid and those remaining on the bottom of the tube; 
the wash fluid from the bottom of the tube also contained 0.22 ~g of proteolytic 1414  PURIFICATION OF  THE  RAT  MAST  CELL  CHYMASE 
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FIG.  8.  Sucrose density gradient ultracentrifugation of chymase,  heparin,  and the two 
combined at various ratios. The mixture applied to the gradients contained chymase alone 
(A), [35S]heparin alone (B), and  [ssS]heparin  and chymase in ratios of 1:12 (C), 1:16 (D), 
and  1:40 (E),  respectively.  In  panel  E,  the  chymase  depicted  represents  the  activity 
washed from the tube bottom and the [35S]heparin represents both the amount washed from 
and that adherent to the tube bottom. Fractions were assayed for [ssS]heparin  ($  e), 
refractive index (&  A) depicted only in panel A, and chymase (©  O) analyzed only 
for panels A and E. 
activity (Fig.  8 E). The isolated granules were localized only to the bottom of 
the tube by recovery of 0.155/~g of proteolytic activity. 
Because the  proteolytic activity of the granule-bound  chymase is not fully 
expressed until the granule is solubilized (10), portions of the natural granules 
or the  1:40  mixture  of native heparin  and  purified  chymase which had  sedi- 
mented to the bottom of the tubes were solubilized in a final concentration of 1 
M  NaC1 for 30 min  at room temperature.  The solubilized samples were then 
diluted with 0.01% gelatin in distilled water so that the final molarity was 0.15 
M NaC1. Unsolubilized samples were also diluted for assay with 0.01% gelatin R.  YURT  AND  K.  F.  AUSTEN  1415 
in 0.15 M NaC1. The proteolytic activity of the isolated granules increased from 
0.155 to 0.494  pg with solubilization, thereby reflecting an overall recovery of 
30%.  The  sedimenting complex formed at the  1:40 ratio  exhibited a  2.8-fold 
increase  in  activity from 0.22  to  0.617  ~g  with  solubilization,  indicating a 
better than 50%  overall recovery of the chymase. Based upon the 0.24  ~  of 
heparin in the same sample, the molar ratio of heparin to chymase was 1:66 in 
the fully sedimented complex formed in the 1:40 original reaction mixture. 
Under the  same  conditions  as  in  the  above  experiment,  neither  heparin 
alone nor heparin with chymase in  a  1:8  ratio  moved into gradients farther 
than the heparin depicted in  Figure  8  B.  At higher ratios of 1:80 and  1:160 
essentially all of the  [~S]heparin recovered sedimented to  the bottom of the 
centrifuge tubes  with  an  overall  recovery in  the  70%  range.  In  a  different 
experiment with centrifugation at only 3,000 g  at the bottom of the gradient for 
1  h,  which  represents  conditions  utilized  to  sediment  granules  in  aqueous 
solution, [~S]heparin alone or in combination with chymase in 1:8, 1:12, or 1:16 
ratios  showed  no  sedimentation.  In  contrast,  a  mixture  of 1:40 resulted  in 
sedimentation  to  the  bottom  of  all  the  heparin  recovered;  recovery  of 
[35S]heparin was 69%. 
Discussion 
A rat mast cell chymotrypsinlike enzyme (chymase) has been preparatively 
purified to homogeneity in order to define its physical and functional interaction 
with  other  mast  cell  granule  constituents.  Inasmuch  as  the  chymase  was 
known  to  be  granule  associated  (4-6),  the  starting  material  for  isolation 
utilized granule-rich subcellular fractions solubilized in 1 M NaC1 to dissociate 
the chymase from macromolecular anionic heparin. The chymase alone, with 
almost all of the protein,  was then separated from the heparin, which is the 
predominant  rat  mast  cell  proteoglycan  (9),  by  Dowex  1  anion  exchange 
chromatography (Fig.  1).  Sephadex G-75 gel filtration separated the chymase 
from much of the protein but did not yield a distinct protein peak in the area of 
chymase activity (Fig.  2).  Binding of the chymase by a  v-tryptophan methyl 
ester  affinity column and elution  at  low pH  yielded concordance between a 
protein peak and chymotryptic activity (Fig.  3). The purified chymase gave a 
single stained protein band on acid disc gel electrophoresis which corresponded 
in position to the region in which function was  recovered by elution from a 
replicate  gel  (Fig.  4).  Electrophoresis in  SDS  after alkylation,  reduction,  or 
both  reduction  and  alkylation  (Fig.  5)  also  revealed a  single  protein.  The 
specific activity of the purified mast cell chymase of 67.8,  62.4,  and 45.1  U/mg 
in three preparations  is  comparable to that obtained by other procedures in 
which homogeneity of the  protein  was  either  not  established  (7,  8)  or  was 
achieved by autodigestion before a final gel filtration step (5). 
The molecular weight of mast cell chymase of approximately 25,000  by gel 
filtration on Sephadex G-75 in the presence of 1.2 M KC1 and 0.01%  gelatin is 
the same as that observed by others (8) with gel filtration under similar buffer 
conditions. Much lower molecular weights of 5,600 by sucrose density ultracen- 
trifugation (6) and 7,000 by gel filtration (8) were obtained with buffers of low 
ionicity. The validity of the 25,000 mol wt figure is established by the identical 1416  PURIFICATION  OF  THE  RAT  MAST  CELL  CHYMASE 
positions  of  mast cell  chymase and ~-chymotrypsin after  alkylation  and electro- 
phoresis in SDS gels (Fig.  5) and is in agreement with the figure  obtained by 
others (5) with the same technique. That mast cell  chymase is cationic  had 
been appreciated by its mobility at alkaline pH and is compatible with the 
amino acid composition of the DFP-treated major granule  protein (6).  The 
cationic nature of  the purified  chymase is apparent from its mobility on acid 
disc gel electrophoresis (Fig.  4) and its failure  to enter the gel on analytic 
alkaline disc  gel electrophoresis.  Although the mast cell  chymase has a size 
and charge comparable to ~-chymotrypsin, it differs  from a-chymotrypsin by 
not revealing two chains when  analyzed  on SDS  gel electrophoresis after 
reduction or reduction and alkylation. 
The Km of  the purified  chymase for  BTEE of  1.56 × 10  -3 is  comparable to the 
value of 1.1 × 10  -3 M  observed with a different  preparation (8).  The purified 
chymase was inhibited  by TPCK and not by TLCK, and the earlier  demonstra- 
tion of both TPCK  and DFP  (8) inhibition  is good evidence that its active 
center is similar to that of a-chymotrypsin,  a-Chymotrypsin  is reversibly 
inhibited  by indoles,  which belong to a family of  monofunctional chymotrypsin 
inhibitors (25),  and preliminary experiments indicated  that 5-HT (serotonin) 
inhibited the action of ~-chymotrypsin on 125I-casein.  5-HT produced a dose- 
dependent inhibition  of the proteolytic  activity  of the isolated  rat mast cell 
chymase (Fig. 6) with a  50% inhibitory dose of 3  ×  10  -3 M. Histamine was not 
significantly  inhibitory at 100 times the 50%  inhibitory dose of 5-HT and did 
not increase or decrease inhibition when introduced in the presence of increas- 
ing doses of 5-HT (Fig.  7).  Based on the rat mast cell content of I  /zg of 5-HT/ 
108  cells  (30)  and  the  rat  mast  cell  granule  volume  of  300  /~m  3  (31),  the 
calculated granule 5-HT in situ molarity of 1.89  ×  10  -2 M is the concentration 
at which 97% inhibition of chymase is seen (Fig. 6). 
Previous experiments  in which rat mast cell granules  were solubilized and 
assessed for micrograms of chymase by using both the amino acid ester and the 
casein  substrates,  and  for  micrograms  of heparin  by  metachromasia  with 
Azure A  revealed a  weight ratio of approximately 1.3 to 1 (10). This value fell 
within the total granule protein to heparin  weight ratio of 2:1 as reported by 
others (4, 28) and was compatible with the finding that the solubilized granule 
contained  a  major protein  considered to be chymase and two less prominent 
proteins (6). The weight ratio of chymase to macromolecular heparin observed 
for  the  isolated  granules  would  give  a  molar  ratio  of 40:1.  When  purified 
chymase and macromolecular heparin were mixed at this ratio and centrifuged 
on sucrose density gradients of 5-30% at 3,000 g  at the bottom of the gradient 
for  1  h,  a  complex  sedimented  as  assessed  by  following  the  radiolabeled 
heparin;  there  was no sedimentation  when lower ratios-of 1:8,  1:12,  and  1:16 
were employed to form the reaction mixture.  When sucrose density gradient 
ultracentrifugation  was extended for 5 h  at 200,000 g  at the gradient bottom, 
34% of the recovered [ssS]heparin in the 1:12 mixture, 40% in the 1:16 mixture, 
and  100% in the  1:40 mixture  sedimented to the bottom (Fig.  8).  Under these 
conditions,  heparin  and  chymase  alone  each  remained  at  the  top  of  the 
gradient.  Solubilization of the material washed from the bottom of the gradient 
tube in  the  1:40 reaction  mixture  gave  55%  recovery of chymase  (0.617  p~g), R.  YURT  AND  K.  F.  AUSTEN  1417 
which,  together with  the  33%  recovery of [35S]heparin  (0.257 ~g),  yields a 
molar ratio of 1:66. The chymase activity sedimented and recovered from the 
h40 mixture compares favorably with the 30% recovery of chymase from the 
isolated granules sedimented under the same conditions. Further, the fact that 
solubilization of the sedimented complex and isolated granules gave a 2.8-fold 
and threefold increment in chymase activity, respectively, argues that masking 
of the active site was similar in the two circumstances. All the data taken 
together for isolated granules and experimental chymase-heparin complexes 
are compatible with a molar ratio in the range of 40-60:1. Based on a heparin 
content of approximately 100 ~g/106 cells (16), a histamine content of 10 ~g/106 
cells (32), and a 5-HT content of 1 ~g/106 cells (30), the approximate molar ratio 
of heparin:chymase:histamine:5-HT is  1:40-66:1,352:42. The  calculation that 
the molar content of 5-HT  is similar to that of chymase, together with the 
finding that 5-HT inhibits chymase function, introduces the possibility that at 
least one site of 5-HT binding in the granule is different from that of histamine. 
Histamine does not inhibit the chymase, is present in appreciable molar excess 
over 5-HT  and chymase, and binds more readily than 5-HT  to  isolated dis- 
charged granules (28). 
The similarity between the rat chymase with respect to molecular weight, 
chemical  inhibition,  and  substrate  specificity  and  the  a-chymotrypsinlike 
enzyme in human peripheral polymorphonuclear  leukocytes (33, 34) is notewor- 
thy because the latter generates chemotactic activity from serum and C3 and 
C5 proteins (35), exhibits bactericidal activity (36), enhances phagocytosis (37) 
and the platelet release reaction (38), and degrades rabbit articular cartilage 
(39). Such a potentiality for the rat mast cell chymase would be regulated by 
two other constituents of the granule. Chymase bound in natural, discharged 
granules  exhibits  only  a  fraction  of the  proteolytic  activity uncovered by 
solubilization.  Whether  5-HT  together with  heparin  completely masks  the 
active site in a truly native granule is unknown. Should solubilization occur by 
mechanisms yet to be defined, 5-HT could function as a reversible active site 
inhibitor. 
Summary 
The rat mast cell granule chymotrypsinlike enzyme was purified to homoge- 
neity from  1  M  NaC1 solubilized  membrane and  granule-rich fractions  of 
concentrated rat  peritoneal mast  cells by a  preparative technique utilizing 
chromatography on Dowex 1, filtration on Sephadex G-75, and affinity chroma- 
tography with D-tryptophan  methyl ester. Acid disk gel electrophoresis of the 
purified chymase disclosed a  single stained band with activity being eluted 
from a replicate sliced gel in the same region. SDS-polyacrylamide gel electro- 
phoresis of purified protein gave a single stained band that did not change in 
position with reduction and alkylation. Mast cell chymase is thus a  cationic 
protein of 25,000 mol wt composed of a single polypeptide chain. The apparent 
Km of the chymase for BTEE was 1.5 x  10  -3 M and the Vmax was 67.8 ~mol/min 
per mg. The enzyme was inhibited by TPCK and not by TLCK. The chymase 
complexed with native macromolecular rat mast cell heparin in molar ratios of 
12:1 and 16:1, and complete heparin uptake occurred at a 40:1 ratio of chymase 1418  PURIFICATION  OF  THE  RAT  MAST  CELL  CHYMASE 
to  heparin.  Chymase  activity  was  partially  masked  by  combination  with 
heparin in the isolated granule or experimental chymase-heparin complex, and 
soluble purified chymase was inhibited by concentrations of 5-HT comparable 
to those present in mast cells.  It is therefore possible that the active site of 
chymase in the mast cell granule is largely masked by the combined effects of 
macromolecular heparin and 5-HT. 
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